Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

24 Downloads (Pure)

Abstract

Lung cancer is the leading cause of cancer-related deaths, and early detection is crucial for improving patient outcomes. Current screening methods using computed tomography have limitations, prompting interest in non-invasive diagnostic tools such as methylated circulating tumor DNA (ctDNA). The PRISMA guidelines for systematic reviews were followed. The electronic databases MEDLINE, Embase, Web of Science, and Cochrane Library were systematically searched for articles. The search string contained three main topics: Lung cancer, blood, and methylated ctDNA. The extraction of data and quality assessment were carried out independently by the reviewers. In total, 33 studies were eligible for inclusion in this systematic review and meta-analysis. The most frequently studied genes were SHOX2, RASSF1A, and APC. The sensitivity and specificity of methylated ctDNA varied across studies, with a summary sensitivity estimate of 46.9% and a summary specificity estimate of 92.9%. The area under the hierarchical summary receiver operating characteristics curve was 0.81. The included studies were generally of acceptable quality, although they lacked information in certain areas. The risk of publication bias was not significant. Based on the findings, methylated ctDNA in blood shows potential as a rule-in tool for lung cancer diagnosis but requires further research, possibly in combination with other biomarkers.

OriginalsprogEngelsk
Artikelnummer3959
TidsskriftCancers
Vol/bind15
Udgave nummer15
Antal sider16
ISSN2072-6694
DOI
StatusUdgivet - 3. aug. 2023

Bibliografisk note

Funding Information:
This research was funded by the Danish Cancer Society via the Danish Comprehensive Cancer Centers: “Danish Research Center for Lung Cancer” and “ctDNA Research Center—The Danish Research Center for Circulating Tumor DNA Guided Cancer Management, Danish Cancer Society (grant no. R257-A14700)”.

Publisher Copyright:
© 2023 by the authors.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Methylated Circulating Tumor DNA in Blood as a Tool for Diagnosing Lung Cancer: A Systematic Review and Meta-Analysis'. Sammen danner de et unikt fingeraftryk.

Citationsformater